Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Escudier

Showing results (51-60 of 189) with videos related to

Pageof 19
Sort By:
Presse Medicale (Paris, France : 1983)|March 28, 1987
[Anastomotic fistula after gastrectomy. Diagnostic value of radiologic monitoring. Retrospective study of 123 gastrectomies]B Escudier, H Belhiba, M Henry-Amar, et al.
Cancer|January 5, 1999
Prognostic factors for survival in patients with brain metastases from renal cell carcinomaS Culine, M Bekradda, A Kramar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
FGFR inhibitor induced peripheral neuropathy in patients with advanced RCCY Loriot, C Massard, E Angevin, et al.
International Journal of Cancer|May 16, 1996
In situ demonstration of renal-cell-carcinoma-specific T-cell clonesA Caignard, M Guillard, C Gaudin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Lithium concentrations during cisplatin-based chemotherapy: evidence for renal interactionF Vincent, T A Bensousan, V Levy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2009
Incidence of brain metastases in renal cell carcinoma treated with sorafenibC Massard, J Zonierek, M Gross-Goupil, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 1998
Phase II study of interferon-alpha and all-trans retinoic acid in metastatic renal cell carcinomaB Escudier, A Ravaud, D Berton, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2B Escudier, F Farace, E Angevin, et al.
Cancer Research|January 15, 1996
T-cell receptor repertoire in neuroblastoma patientsD Valteau, V Scott, G Carcelain, et al.
Endocrine-Related Cancer|September 3, 2015
Insulin and IGFs in renal cancer risk and progressionW Solarek, A M Czarnecka, B Escudier, et al.
Pageof 19

Showing results (51-60 of 189) with videos related to

Sort By:
Pageof 19
Presse Medicale (Paris, France : 1983)|March 28, 1987
[Anastomotic fistula after gastrectomy. Diagnostic value of radiologic monitoring. Retrospective study of 123 gastrectomies]B Escudier, H Belhiba, M Henry-Amar, et al.
Cancer|January 5, 1999
Prognostic factors for survival in patients with brain metastases from renal cell carcinomaS Culine, M Bekradda, A Kramar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
FGFR inhibitor induced peripheral neuropathy in patients with advanced RCCY Loriot, C Massard, E Angevin, et al.
International Journal of Cancer|May 16, 1996
In situ demonstration of renal-cell-carcinoma-specific T-cell clonesA Caignard, M Guillard, C Gaudin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Lithium concentrations during cisplatin-based chemotherapy: evidence for renal interactionF Vincent, T A Bensousan, V Levy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2009
Incidence of brain metastases in renal cell carcinoma treated with sorafenibC Massard, J Zonierek, M Gross-Goupil, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 1998
Phase II study of interferon-alpha and all-trans retinoic acid in metastatic renal cell carcinomaB Escudier, A Ravaud, D Berton, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2B Escudier, F Farace, E Angevin, et al.
Cancer Research|January 15, 1996
T-cell receptor repertoire in neuroblastoma patientsD Valteau, V Scott, G Carcelain, et al.
Endocrine-Related Cancer|September 3, 2015
Insulin and IGFs in renal cancer risk and progressionW Solarek, A M Czarnecka, B Escudier, et al.
Pageof 19